Ryo Saito

Hiroshima, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Extended-Interval Dosing and Discontinuation of Dupilumab in Atopic Dermatitis: A Real-World Retrospective Study.

Extended-Interval Dosing and Discontinuation of Dupilumab in Atopic Dermatitis: A Real-World Retrospective Study.

Journal: The Journal of dermatology

Published: April 24, 2026

Allosteric switching of Ca2+ permeability in the lysosomal ion channel TPC2 underpins biased agonist activation.

Allosteric switching of Ca2+ permeability in the lysosomal ion channel TPC2 underpins biased agonist activation.

Journal: The EMBO journal

Published: November 03, 2025

A Case of Multiple Recalcitrant Verruca Vulgaris Associated With Atopic Dermatitis Successfully Treated With Nemolizumab and Topical Imiquimod.

A Case of Multiple Recalcitrant Verruca Vulgaris Associated With Atopic Dermatitis Successfully Treated With Nemolizumab and Topical Imiquimod.

Journal: The Journal of dermatology

Published: October 29, 2025

Disease Duration of Urticaria: A Sub-Analysis of a Survey on Subtypes and Clinical Characteristics of 1061 Patients With Urticaria in the Primary Care Institutes in Japan.

Disease Duration of Urticaria: A Sub-Analysis of a Survey on Subtypes and Clinical Characteristics of 1061 Patients With Urticaria in the Primary Care Institutes in Japan.

Journal: The Journal of dermatology

Published: July 24, 2025

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan.

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan.

Journal: The Journal of dermatology

Published: May 12, 2025

Oncostatin M enhances the lengthening of sensory nerves and skin hypersensitivity.

Oncostatin M enhances the lengthening of sensory nerves and skin hypersensitivity.

Journal: Frontiers in immunology

Published: February 06, 2025

Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis.

Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: September 22, 2023

Convergent activation of Ca2+ permeability in two-pore channel 2 through distinct molecular routes.

Convergent activation of Ca2+ permeability in two-pore channel 2 through distinct molecular routes.

Journal: Science signaling

Published: August 22, 2023

Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching.

Oncostatin M suppresses IL31RA expression in dorsal root ganglia and interleukin-31-induced itching.

Journal: Frontiers in immunology

Published: June 30, 2023

The ability of biomarkers to assess the severity of atopic dermatitis.

The ability of biomarkers to assess the severity of atopic dermatitis.

Journal: The journal of allergy and clinical immunology. Global

Published: April 22, 2023

A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan.

A survey on subtypes and clinical characteristics of 1061 patients with urticaria in the primary care institutes in Japan.

Journal: The Journal of dermatology

Published: April 01, 2022

Real-world efficacy of proactive maintenance treatment with delgocitinib ointment twice weekly in adult patients with atopic dermatitis.

Real-world efficacy of proactive maintenance treatment with delgocitinib ointment twice weekly in adult patients with atopic dermatitis.

Journal: Dermatologic therapy

Published: February 09, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026